Publications by authors named "Ilhan Lim"

Claim this Profile
A
Ac-NOTA-trastuzumab human dosimetry using inter-radionuclide and biological half-life based allometric extrapolation method.
Muath Almaslamani, Kangsan Kim, Kwang Il Kim, Ilhan Lim, Hyun-Ah Kim

EJNMMI Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical perspective on targeted alpha therapy using Ac.
Ilhan Lim

Ann Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the Gap in Theranostics: Where Do We Stand?
Hee-Seung Henry Bom, Ilhan Lim

Nucl Med Mol Imaging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutoff SUVR of [F]Florapronol PET for Differentiating Alzheimer's Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume Correction.
Su Yeon Park, Inki Lee, Ilhan Lim, Byung Il Kim, Chang Woon Choi

Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-18 FDG PET/CT Clinical Service Trends in Korea from 2018 to 2022: A National Surveillance Study.
Jaesun Yoon, Heejin Kim, Do Hyun Woo, Seung Yeop Chae, Ji Heui Lee, Ilhan Lim

Nucl Med Mol Imaging· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning-based organ-wise dosimetry of Cu-DOTA-rituximab through only one scanning.
Kangsan Kim, Jingyu Yang, Muath Almaslamani, Chi Soo Kang, Inki Lee, Ilhan Lim

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating 64 Cu-DOTA-rituximab as a PET agent in patients with B-cell lymphoma: a head-to-head comparison with 18 F-fluorodeoxyglucose PET/computed tomography.
Inki Lee, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Hye Jin Kang, Ilhan Lim

Nucl Med Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-isotope imaging method for Actinium-225 and Bismuth-213 using alpha imaging detector.
Jong-Guk Kim, Guna Kim, Hyun Su Lee, Byoungsoo Kim, Il-Han Lim

Appl Radiat Isot· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/MRI and Novel Targets for Breast Cancer.
Hyun Woo Chung, Kyoung Sik Park, Ilhan Lim, Woo Chul Noh, Young Bum Yoo

Biomedicines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy with I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim

Asia Pac J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.
Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim

Clin Med Insights Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning-Based Delayed PET Image Synthesis from Corresponding Early Scanned PET for Dosimetry Uptake Estimation.
Kangsan Kim, Byung Hyun Byun, Ilhan Lim, Sang Moo Lim, Sang-Keun Woo

Diagnostics (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression.
Inki Lee, Ilhan Lim, Kyo Chul Lee, Hye Jin Kang, Sang Moo Lim

Clin Nucl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes.
Hye Min Ju, Byung-Chul Kim, Ilhan Lim, Byung Hyun Byun, Sang-Keun Woo

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
Joon Ho Choi, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang Moo Lim

PLoS One· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of F-DCFPyL, F-NaF, and F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer.
Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, Joanna J Shih, Baris Turkbey, Ilhan Lim

J Nucl Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prediction of HER2-Targeted Treatment Response Using Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report.
Inki Lee, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang Moo Lim

J Breast Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center F-FDG PET Images.
Jingyu Kim, Su Young Jeong, Byung-Chul Kim, Byung-Hyun Byun, Ilhan Lim, Sang Moo Lim

Diagnostics (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor.
Hansol Moon, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Sang Moo Lim

Clin Nucl Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental 18F-Florapronol Uptake in Meningioma.
Inki Lee, Joon Seog Kong, Sang Min Youn, Ilhan Lim, Jeong Ho Ha

Clin Nucl Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of I-trastuzumab and lanatoside C enhanced therapeutic efficacy in HER2 positive tumor model.
Nagarajan Vinod, Jae Hyung Kim, Seungbum Choi, Ilhan Lim

Sci Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of Ac-DOTA-rituximab using Cu-DOTA-rituximab.
Chul-Hee Lee, Ilhan Lim, Sang-Keun Woo, Wook Kim, Kwang Il Kim, Sang Moo Lim

Ann Nucl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using F-FDF PET/CT, and .
Byung-Chul Kim, Jingyu Kim, Kangsan Kim, Byung Hyun Byun, Ilhan Lim

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An X-ray spectrum estimation method from transmission measurement combined with scatter correction.
Guna Kim, Hyosung Cho, Ilhan Lim, Kanghyon Song, Jong-Guk Kim

Phys Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary clinical trial to evaluate Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.
Inki Lee, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang Moo Lim

EJNMMI Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis